The discovery of Mary's mutation

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 2, 2003, Pages 397-398

  Asselta, R ^a   Tenchini, M L ^a   Holme, R ^b   Brosstad, F ^b   Stormorken, H ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5;

AMINO ACID SUBSTITUTION; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CHEMISTRY; FEMALE; GENETICS; HISTORY; HUMAN; NORWAY; NOTE; POINT MUTATION;

AMINO ACID SUBSTITUTION; FACTOR V; FACTOR V DEFICIENCY; FEMALE; HISTORY, 20TH CENTURY; HUMANS; NORWAY; POINT MUTATION;

EID: 0141561921     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00151.x     Document Type: Letter

References (12)

1. Stormorken H. The discovery of factor V, a tricky clotting factor. J Thromb Haemost 2003; 1: 206-13.
2. Owren PA. Parahaemophilia haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet 1947; 1: 446-8.
3. Guasch JF, Cannegieter S, Reitsma PH, van't Veer-Korthof ET, Bertina RM. Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene. Br J Haematol 1998; 101: 32-9.
4. Duga S, Montefusco MC, Asselta R, Malcovati M, Peyvandi F, Santagostino E, Mannucci PM, Tenchini ML. R2074C missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein. Blood 2003; 101: 173-7.
5. Koeleman BP, Reitsma PH, Bakker E, Bertina RM. Location on the human genetic linkage map of 26 genes involved in blood coagulation. Thromb Haemost 1997; 77: 873-8.
6. Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002; 8: 308-21.
7. Lunghi B, Iacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti G, Bernardi F. Detection of new polymorphic markers in the Factor V gene: association with Factor V levels in plasma. Thromb Haemost 1996; 75: 45-8.
8. Guasch JF, Lensen RPM, Bertina RM. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is 'pseudo homozygous' for activated protein C resistance. Thromb Haemost 1997; 77: 252-7.
9. Macedo-Ribeiro S, BodeW, Huber R, Quinn-Allen MA, Kim SW, Ortel TL, Bourenkov GP, Bartunik HD, Stubbs MT, Kane WH, Fuentes-Prior P. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature 1999; 402: 434-9.
10. Schrijver I, Houissa-Kastally R, Jones CD, Garcia KC, Zehnder JL. Novel factor V C2-domain mutation (R2074H) in two families with factor V deficiency and bleeding. Thromb Haemost 2002; 87: 294-9.
11. Bossone A, D'Angelo F, De Santacroce R, Lucia D, Margaglione M. Factor VArg2074Cys: a novel missense mutation in the C2 domain of factor V. Thromb Haemost 2002; 87: 923-4.
12. Reiersen H, Rees AR. The hunchback and its neighbours: proline as an environmental modulator. Trends Biochem Sci 2001; 26: 679-84.